A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/9343463
Conclusion of this study
EGb was safe and appears capable of stabilizing and, in a substantial number of cases, improving the cognitive performance and the social functioning of demented patients for 6 months to 1 year. Although modest, the changes induced by EGb were objectively measured by the ADAS-Cog and were of sufficient magnitude to be recognized by the caregivers in the GERRI.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study